A detailed history of Caitlin John, LLC transactions in Novartis Ag stock. As of the latest transaction made, Caitlin John, LLC holds 54 shares of NVS stock, worth $5,565. This represents 0.0% of its overall portfolio holdings.

Number of Shares
54
Previous 123 56.1%
Holding current value
$5,565
Previous $12.5 Million 54.85%
% of portfolio
0.0%
Previous 0.01%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$106.13 - $120.89 $7,322 - $8,341
-69 Reduced 56.1%
54 $5.62 Million
Q4 2023

Feb 14, 2024

BUY
$92.27 - $101.54 $11,349 - $12,489
123 New
123 $12.5 Million

Others Institutions Holding NVS

About NOVARTIS AG


  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $222B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Caitlin John, LLC Portfolio

Follow Caitlin John, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Caitlin John, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Caitlin John, LLC with notifications on news.